Encapsulation techniques Peptides can be enclosed within microparticles or nanoparticles, protecting them from digestive enzymes
Developed by Sino Biopharm, the patch is the first domestically produced rivastigmine transdermal patch approved for marketing
Jane Iredale Clean, skin loving, mineral makeup
GLP-1 injections or glucagon-like peptide-1 agonists are a class of injectable medications used in the treatment of type 2 diabetes and obesity
The agency placed 19 peptides into "Category 2" of the FDA's 503A Bulk Drug Substances list

Patients should seek medical advice if headaches are accompanied by: Neurological symptoms : Vision changes, weakness, numbness, difficulty speaking, confusion, or loss of consciousness Severe nausea and vomiting : Particularly if unable to maintain adequate hydration or take medications for more than 24 hours Signs of dehydration : Markedly decreased urination, dark urine, dizziness, rapid heartbeat, or dry mucous membranes Fever or neck stiffness : Which may suggest infection requiring evaluation Changes in headache pattern : New characteristics in patients with pre-existing headache disorders New onset after age 50 : Headaches beginning later in life require evaluation Severe, persistent abdominal pain with or without vomiting : May indicate pancreatitis, a rare but serious side effect of GLP-1 medications requiring immediate medical attention Healthcare providers may recommend several approaches when evaluating persistent headaches